Cosaic Secures $6M to Scale Yeast‑Based Emulsifier Targeting Dairy and Egg Additive Replacement

Context Cosaic, formerly known as Cultivated Biosciences, focuses on developing multifunctional ingredients through its proprietary yeast fermentation platform. Its lead product, Cosaic Neo, functions as a yeast-derived emulsifier—a substance that stabilizes mixtures of oil and water—and aims to deliver creaminess, stability, and functionality to food and drink applications. The company positions this ingredient as a solution for food manufacturers seeking cleaner labels and improved product performance without relying on conventional dairy, egg, or industrial plant-based formulations.

Key Facts The company secured $6 million in a seed extension round, led by DSM-Firmenich Ventures, the venture arm of the chemicals and ingredients corporation. This investment brings Cosaic's total funding to $12.5 million. Cosaic Neo itself contains 8-15% protein, 45-60% fat (with 13-22% of that being saturated fat), and 25-45% fiber, offering a robust nutritional profile alongside its functional benefits. Tomas Turner, Cosaic's CEO, stated the company is building an ingredient that "resolves the trade-offs food companies face every day between clean label, sensory performance, and cost." The ingredient is produced by cultivating a non-GMO oleaginous yeast strain in a bioreactor, followed by a non-chemical extraction process.

What It Means The new capital infusion targets three key business priorities: accelerating regulatory approvals in the US and Europe, scaling up production with a contract manufacturer, and initiating industrial trials with large clients. Cosaic Neo can replace multiple single-purpose ingredients, providing bulk, nutrition, and stability in products like ready-to-drink protein shakes, coffee creamers, non-dairy milks, and sauces. The company targets the US market initially, citing a more expedited regulatory process. This funding round signals investor confidence in Cosaic's technology and its potential to address consumer demand for simpler, more transparent food ingredients. The success comes amidst a challenging fundraising landscape for fermentation startups, highlighting Cosaic's strategic value proposition.

What to watch next: Cosaic's progress on regulatory approvals and the rollout of its industrial trials will indicate its path toward broader market entry and product commercialization.